7Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, Bade J, Kochi A, Dye C, Raviglione MC. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries[J]. JAMA, 2000, 283(19): 2537-2545.
8Ohkado A, Aguiman L, Adlawan S, Baring E, Quirante O, Su- chi M, Endo, S, Fujiki A, Mori T. Tuberculosis drug-resist- ance and treatment outcomes under DOTS settings in large city in the Philippines[J]. Int J Tuberc Lung Dis, 2006,10:283- 289.
9Arevalo M, Solera J, Cebrian D, Bartolome J, Robles P. Risk factors associated with drug-resistant Myeobacterium tuberculosis inCastilla-la Mancha (Spain)[J]. Eur Respir J, 1996, 9(2): 274-278.
10Palwstwicha.Tuberculosis in Thailand[J].Respirology,2001,6(1):65-70.
